3-Cyclopropyl-1-ethyl-1H-pyrazol-5-amine, 95.0%, 100mg

methyl 5-(methanesulfonylmethyl)furan-2-carboxylate, 250mg

2-METHYL-5-[4-(4,4,5,5-TETRAMETHYL-1,3,2-DIOXABOROLAN-2-YL)PHENYL]-1,3,4-OXADIAZOLE, 95.0%, 250mg

methyl 5-(aminomethyl)-2-furoate hydrochloride, 95.0%, 1g

(1S,4S)-tert-Butyl 3-oxo-2-oxa-5-azabicyclo[2.2.1]heptane-5-carboxylate, 95.0%, 1g

4-Iodo-2-methoxy-5-methylpyridine, 97%, 100mg

Plan PLi 10x/0.25 IOS objetivo corregido al infinito

tert-Butyl 5-bromo-1,2,3,6-tetrahydropyridine-1-carboxylate, 95.0%, 1g

[3-fluoro-4-(2,2,2-trifluoroethoxy)phenyl]amine, 1g

3-Methylimidazo[2,1-b]thiazole-2-carboxylic acid, 95.0%, 250mg

2,4-Dimethylpentan-3-amine hydrochloride, 95.0%, 1g

2-(Difluoromethyl)benzimidazole>98.0%(GC)(T)5g

6-Amino-5-propylamino-1-methyluracil, 98%, 1g